Interventions to promote mammography screening don't seem to work

Article

Neither tailored nor targeted interventions have any significant effect on mammography screening rates, according to two studies published in the Mar. 5 issue of the Journal of the National Cancer Institute.

Neither tailored nor targeted interventions have any significant effect on mammography screening rates, according to two studies published in the Mar. 5 issue of the Journal of the National Cancer Institute.

In the first study, Sally W. Vernon, PhD, from the University of Texas-Houston School of Public Health, and colleagues randomly assigned 5,500 female veterans (≥52 years) to one of three strategies to increase mammography screening: tailored and targeted, targeted only, and a survey-only control group. The investigators found that neither intervention had any significant effect on mammography rates.

In the second study, Deborah J. del Junco, PhD, from the same institution, and colleagues randomly assigned 21,340 women (≥52 years) to one of five groups as part of a trial to promote mammography screening: groups 1-3 received baseline surveys and groups 1-2 received varied personalization materials. Group 4 received a post-intervention survey at year 1 and group 5 received a post-intervention survey at year 2, both of which coincided with follow-up surveys to groups 1-3.

“Groups 1-3 were similar throughout the trial in participation and correlates of mammography screening. No statistically significant survey cueing effects or differences between nonparticipants and participants across groups were observed,” del Junco’s team found Vernon SW, del Junco DJ, Tiro JA , et al. Promoting regular mammography screening II. Results from a randomized controlled trial in US women veterans. J Natl Cancer Inst. 2008;100:347-348. Published online at doi:10.1093/jnci/djn026.

del Junco DJ, Vernon SW, Coan SP, et al. Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial. J Natl Cancer Inst. 2008;100:333-346. Published online at doi:10.1093/jnci/djn027.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.